Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,814 papers from all fields of science
Search
Sign In
Create Free Account
Percent Free Prostate-Specific Antigen Measurement
Known as:
Free Prostate-Specific Antigen
, Percent Free Prostate-Specific Antigen
, free PSA
The amount of the protein prostate-specific antigen (PSA) in the blood that is not attached to other proteins. It is compared with the amount of PSA…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The Prostate Health Index: a new test for the detection of prostate cancer
S. Loeb
,
W. Catalona
Therapeutic Advances in Urology
2014
Corpus ID: 12337615
A major focus in urologic research is the identification of new biomarkers with improved specificity for clinically-significant…
Expand
Highly Cited
2011
Highly Cited
2011
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml…
G. Guazzoni
,
L. Nava
,
+10 authors
P. Rigatti
European Urology
2011
Corpus ID: 207619605
Highly Cited
2010
Highly Cited
2010
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.
Flip H. Jansen
,
R. V. van Schaik
,
+7 authors
G. Bartsch
European Urology
2010
Corpus ID: 6126899
Highly Cited
2009
Highly Cited
2009
A [‐2]proPSA‐based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases
C. Stephan
,
Anna-Maria Kahrs
,
+5 authors
K. Jung
The Prostate
2009
Corpus ID: 22742439
The aim of this study was to combine the new automated Access [‐2]proPSA (p2PSA) assay with a percent free PSA (%fPSA) based…
Expand
Highly Cited
2006
Highly Cited
2006
A meta-analysis of the performance characteristics of the free prostate-specific antigen test.
R. Lee
,
A. Localio
,
K. Armstrong
,
K. Armstrong
,
S. Malkowicz
,
J. Schwartz
Urology
2006
Corpus ID: 25334089
Highly Cited
2003
Highly Cited
2003
Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels.
Desirée S. Grubisha
,
R. J. Lipert
,
Hye-Young Park
,
J. Driskell
,
M. Porter
Analytical Chemistry
2003
Corpus ID: 22863792
A novel reagent for low-level detection in immunoadsorbent assays is described. The reagent consists of gold nanoparticles…
Expand
Highly Cited
2003
Highly Cited
2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis.
L. Sokoll
,
D. Chan
,
+9 authors
A. Partin
Urology
2003
Corpus ID: 42164712
Highly Cited
1998
Highly Cited
1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
W. Catalona
,
A. Partin
,
+13 authors
P. Southwick
Journal of the American Medical Association (JAMA…
1998
Corpus ID: 26821369
Highly Cited
1996
Highly Cited
1996
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age.
A. Partin
,
W. Catalona
,
P. Southwick
,
E. N. Subong
,
G. H. Gasior
,
D. Chan
Urology
1996
Corpus ID: 11614829
Highly Cited
1995
Highly Cited
1995
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
W. Catalona
,
Deborah S. Smith
,
+4 authors
R. B. Nadler
Journal of the American Medical Association (JAMA…
1995
Corpus ID: 21909854
OBJECTIVE To evaluate measurement of percentage of free prostate-specific antigen (PSA) in serum to improve the specificity of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE